Cagrilintide - 5mg

Description

5mg of Lyophilized product in a 3ml vial

This product needs to be reconstituted before use

Cagripeptide, classified as an amycretin, is a novel investigational peptide that emulates the effects of endogenous gut hormones responsible for appetite regulation and satiety signaling. By specifically engaging with brain receptors linked to the feeling of fullness, it aims to suppress hunger, facilitating weight loss by promoting reduced caloric intake. This innovative mechanism, centered on the pathways of the central nervous system, is designed to induce a durable sensation of satiety, assisting in effective weight management strategies. Currently under clinical investigation for its potential in addressing obesity and its associated metabolic disorders, cagripeptide represents an exciting prospect in the pharmacological field of weight control.

Cagripeptide is intended for research or lab use only and is not approved for any form of in vivo use. Please read and adhere to our terms and conditions before ordering.